<unk>  <unk> ; also known as HIV<unk> , HIV encephalopathy and HIV-associated<unk>  has become a common neurological disorder associated with HIV infection and<unk> . It is a metabolic encephalopathy induced by HIV infection and fueled by immune activation of brain macrophages and microglia. These cells are actively infected with HIV and secrete neurotoxins of both host and viral origin. The essential features of<unk>  are disabling cognitive impairment accompanied by motor dysfunction, speech problems and behavioral change. Cognitive impairment is characterised by mental slowness, trouble with memory and poor concentration. Motor symptoms include a loss of fine motor control leading to clumsiness, poor balance and tremors. Behavioral changes may include apathy, lethargy and diminished emotional responses and spontaneity. Histopathologically, it is identified by the infiltration of monocytes and macrophages into the central nervous system (CNS), gliosis, pallor of myelin sheaths, abnormalities of dendritic processes and neuronal apoptosis.<unk>  typically occurs after years of HIV infection and is associated with low CD4+ T cell levels and high plasma viral loads. It is sometimes seen as the first sign of the onset of<unk> . Prevalence is between 10-20% in Western countries and has only been seen in 1-2% of India based infections. This has to due to with differences in diets, such as consumption of curcumin (in curry) and EGCG or Theaflavins (in teas), both which can pass the blood brain barrier and have neuroprotective effects.  With the advent of highly active antiretroviral therapy (HAART), the frequency of<unk>  has declined in developed countries. HAART may not only prevent or delay the onset of<unk>  in people with HIV infection, it can also improve mental function in people who already have<unk> .<unk>  only exists when neurocognitive impairment in the patient is severe enough to interfere markedly with day-to-day function. That is, the patient is typically unable to work and may not be able to take care of him or herself. Before this, the patient is said to have a mild neurocognitive disorder.
AIDS dementia complex
Bickerstaff's encephalitis
Rasmussen's encephalitis
Creutzfeldt-Jakob disease diagnostic criteria
Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease classification
Hashimoto's encephalopathy
La Crosse encephalitis